Panagene Inc (046210) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Panagene Inc (046210) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.17 Million ≈ $31.29K USD) by net assets (₩77.27 Billion ≈ $52.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Panagene Inc (046210) net asset quality to measure how much of total assets are equity-financed.

Panagene Inc - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Panagene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Panagene Inc to evaluate the quality of earnings relative to operating cash generation.

Panagene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panagene Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TherapeuticsMD Inc NASDAQ:TXMD	0.051x
NamSys Inc V:CTZ	0.102x
Wing Yip Food Holdings Group Limited American Depositary Shares NASDAQ:WYHG	0.026x
Resverlogix Corp. TO:RVX	0.011x
Pudjiadi & Sons Tbk JK:PNSE	0.115x
TURBOMECANICA S.A. RO:TBM	-0.014x
Master Pack Group Bhd KLSE:7029	0.021x
Andromeda Metals Ltd AU:ADN	-0.013x

Annual Cash Flow Conversion Efficiency for Panagene Inc (2006–2024)

The table below shows the annual cash flow conversion efficiency of Panagene Inc from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Panagene Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.04 Billion ≈ $51.53 Million	₩346.54 Million ≈ $234.84K	0.005x	+701.91%
2023-12-31	₩63.57 Billion ≈ $43.08 Million	₩36.13 Million ≈ $24.48K	0.001x	-99.46%
2022-12-31	₩31.69 Billion ≈ $21.48 Million	₩3.36 Billion ≈ $2.28 Million	0.106x	-47.35%
2021-12-31	₩29.84 Billion ≈ $20.22 Million	₩6.01 Billion ≈ $4.07 Million	0.201x	+19.31%
2020-12-31	₩25.07 Billion ≈ $16.99 Million	₩4.23 Billion ≈ $2.87 Million	0.169x	+225.83%
2019-12-31	₩20.20 Billion ≈ $13.69 Million	₩1.05 Billion ≈ $709.60K	0.052x	-17.13%
2018-12-31	₩16.30 Billion ≈ $11.05 Million	₩1.02 Billion ≈ $690.98K	0.063x	+158.64%
2017-12-31	₩19.84 Billion ≈ $13.44 Million	₩-2.12 Billion ≈ $-1.43 Million	-0.107x	-100.63%
2016-12-31	₩21.10 Billion ≈ $14.30 Million	₩-1.12 Billion ≈ $-760.05K	-0.053x	-30.35%
2015-12-31	₩8.91 Billion ≈ $6.04 Million	₩-363.21 Million ≈ $-246.14K	-0.041x	-107.56%
2012-12-31	₩8.92 Billion ≈ $6.05 Million	₩4.81 Billion ≈ $3.26 Million	0.539x	+333.48%
2011-12-31	₩15.94 Billion ≈ $10.80 Million	₩-3.68 Billion ≈ $-2.50 Million	-0.231x	-104.70%
2010-12-31	₩16.66 Billion ≈ $11.29 Million	₩-1.88 Billion ≈ $-1.27 Million	-0.113x	+53.02%
2009-12-31	₩17.92 Billion ≈ $12.15 Million	₩-4.31 Billion ≈ $-2.92 Million	-0.240x	-514.69%
2008-12-31	₩25.88 Billion ≈ $17.54 Million	₩1.50 Billion ≈ $1.02 Million	0.058x	-7.83%
2007-12-31	₩34.14 Billion ≈ $23.14 Million	₩2.15 Billion ≈ $1.45 Million	0.063x	+41.98%
2006-12-31	₩30.94 Billion ≈ $20.97 Million	₩1.37 Billion ≈ $928.01K	0.044x	--

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$22.91 Million

₩33.81 Billion KRW

Market Cap Rank

#24627 Global

#1749 in Korea

Share Price

₩1052.00

Change (1 day)

+1.94%

52-Week Range

₩999.00 - ₩2650.00

All Time High

₩12000.00